Should I Buy ARTW? ARTW 2026 Analysis

Should You Buy Art's Way Manufacturing Co Inc (ARTW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

2.380

1 Day change

3.48%

52 Week Range

4.710

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: price is stretched/overbought and sitting just below nearby resistance, which is a poor entry for an impatient buyer.
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.
Near-term pattern stats lean bearish: similar-pattern study implies slight up next day, but down next week/month bias.
Fundamentals show revenue growth but sharply weaker profitability, reducing conviction to buy strength ahead of the next earnings (2026-02-17 pre-market).

Technical Analysis

Trend/Momentum: MACD histogram positive and expanding (bullish momentum), but RSI(6) at ~93.9 signals extreme overbought conditions.
Moving averages: converging MAs suggest the trend is not firmly established and may be prone to whipsaw.
Key levels (pre-market ~2.81): Pivot 2.608; Resistance R1 2.822 (very close overhead), R2 2.954; Supports S1 2.394, S2 2.262.
Setup quality: buying at ~2.81 offers limited upside to first resistance (2.822) with more room to downside back toward pivot/supports—unfavorable risk/reward for a “buy now” decision.

Positive Catalysts

- MACD momentum is improving (positive/expanding histogram), indicating recent buyers have had control.
- Revenue grew +9.47% YoY in 2025/Q3.
- Upcoming earnings date (2026-02-17 pre-market) can act as a catalyst if results meaningfully rebound.

Neutral/Negative Catalysts

- RSI is extremely overbought, increasing odds of a near-term pullback.
- Price is pressing into resistance at 2.822; a rejection can quickly send shares back toward 2.608 / 2.394.
- Similar-pattern forward probabilities point to -1.89% (1 week) and -4.01% (1 month).
- No supportive news flow in the last week.
- No notable hedge fund/insider accumulation signals (both neutral).
- No recent congress trading data available (no influential buying signal to lean on).

Financial Performance

Latest quarter: 2025/Q3
Revenue: $6.43M, +9.47% YoY (top-line growth positive).
Profitability deteriorated sharply: Net income $254K, -1069.89% YoY; EPS $0.05, -600% YoY.
Gross margin: 27.46%, down ~5.08% YoY, suggesting weaker pricing power and/or higher costs.
Overall: growth exists, but the earnings/margin trend is negative, which weakens the case for chasing the current overbought move.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data provided.
Wall Street pro/con view (based on available data only): Pros = improving revenue and recent price momentum; Cons = collapsing YoY profitability/margins, overbought technicals, and no confirming external sentiment signals (options/analysts/congress/insiders).

Analyst Rating

Wall Street analysts forecast ARTW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARTW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold